Optimising Corticosteroid Use in Alcoholic Hepatitis Management

Created using ChatSlide

This presentation provides a comprehensive overview of the STASH trial, which investigates the treatment of alcohol-associated hepatitis (AAH) through corticosteroid use. Key topics include the open-label multicentre methodology, participant criteria, intervention methods, and the primary outcome concerning the 90-day infection rate along with secondary outcomes like mortality and acute kidney injury (AKI). The trial enrolled 254 participants, focusing on the statistical significance of...